BCL2-Interacting Killer (Apoptosis-Inducing) (BIK) (N-Term) Peptide
Our Local Distributor
北京 101111
Quick Overview for BCL2-Interacting Killer (Apoptosis-Inducing) (BIK) (N-Term) Peptide (ABIN5512171)
抗原
宿主
资源
应用范围
-
-
蛋白结构域
- N-Term
-
序列
- SEVRPLSRDI LMETLLYEQL LEPPTMEVLG MTDSEEDLDP MEDFDSLECM
-
产品特性
- This is a synthetic peptide designed for use in combination with anti-BIK Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
储存条件
- -20 °C
-
储存方法
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- BIK (BCL2-Interacting Killer (Apoptosis-Inducing) (BIK))
-
背景
-
The protein encoded by this gene shares a critical BH3 domain with other death-promoting proteins, such as BID, BAK, BAD and BAX, that is required for its pro-apoptotic activity, and for interaction with anti-apoptotic members of the BCL2 family, and viral survival-promoting proteins. Since the activity of this protein is suppressed in the presence of survival-promoting proteins, it is suggested as a likely target for anti-apoptotic proteins.
Alias Symbols: BIK,NBK,
Protein Size: 160 -
基因ID
- 638
-
NCBI登录号
- NP_001188
-
UniProt
- Q13323
抗原
-